Skip to main content
Lancet (London, England)
Public health and international drug policy.
The Lancet Commission on tuberculosis: building a tuberculosis-free world.
Global governance of antimicrobial resistance.
Community-associated meticillin-resistant Staphylococcus aureus.
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.
Antiretroviral therapy: stubborn limitations persist.
Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial.
Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial.
Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial.
Home management of malaria with artemether-lumefantrine compared with standard care in urban Ugandan children: a randomised controlled trial.
